Targeting the microenvironment in solid tumors
- PMID: 29502037
- DOI: 10.1016/j.ctrv.2018.02.004
Targeting the microenvironment in solid tumors
Abstract
Tumorigenesis is a complex and dynamic process involving different cellular and non-cellular elements composed of tumor microenvironment (TME). The interaction of TME with cancer cells is responsible for tumor development, progression and drug resistance. TME consists of non malignant cells of the tumor such as cancer associated fibroblasts (CAFs), endothelial cells and pericytes composing tumor vasculature, immune and inflammatory cells, bone marrow derived cells, and the extracellular matrix (ECM) establishing a complex cross-talk with tumor. These interactions contribute towards proliferation and invasion of the tumor by producing growth factors, chemokines and matrix-degrading enzymes. ECM is a complex system containing macromolecules with distinctive physical, biochemical and biomechanical properties. During tumorigenesis this system is deregulated favoring the generation of tumorigenic microenvironment enhancing tumor-associated angiogenesis and inflammation. An important step of anticancer treatment is the identification of the biological alterations present in TME in order to target these key molecular players. Multitargeted approaches, providing a simultaneous inhibition of TME components, may offer a more efficient way to treat cancer. In this manuscript we overview the function of each components of TME and the treatments targeting the key players.
Keywords: Bone marrow derived cells; Cancer-associated fibroblasts; Endothelial cells; Extracellular matrix; Immune cells; Tumor microenvironment.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Targeting Tumor Microenvironment for Cancer Therapy.Int J Mol Sci. 2019 Feb 15;20(4):840. doi: 10.3390/ijms20040840. Int J Mol Sci. 2019. PMID: 30781344 Free PMC article. Review.
-
DNA methylation in the tumor microenvironment.J Zhejiang Univ Sci B. 2017 May;18(5):365-372. doi: 10.1631/jzus.B1600579. J Zhejiang Univ Sci B. 2017. PMID: 28471108 Free PMC article. Review.
-
Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.Adv Exp Med Biol. 2020;1277:143-158. doi: 10.1007/978-3-030-50224-9_10. Adv Exp Med Biol. 2020. PMID: 33119871
-
[Tumor microenvironment: promising therapeutic target].Nihon Rinsho. 2015 Aug;73(8):1283-7. Nihon Rinsho. 2015. PMID: 26281679 Review. Japanese.
-
MicroRNAs in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1277:1-31. doi: 10.1007/978-3-030-50224-9_1. Adv Exp Med Biol. 2020. PMID: 33119862 Review.
Cited by
-
A Multivalent DNA Nanoparticle/Peptide Hybrid Molecular Modality for the Modulation of Protein-Protein Interactions in the Tumor Microenvironment.Adv Nanobiomed Res. 2024 Jul;4(7):2300159. doi: 10.1002/anbr.202300159. Epub 2024 Apr 25. Adv Nanobiomed Res. 2024. PMID: 39328775
-
Melatonin for gastric cancer treatment: where do we stand?Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep 17. doi: 10.1007/s00210-024-03451-7. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39287677 Review.
-
Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration.Heliyon. 2024 Aug 23;10(17):e36819. doi: 10.1016/j.heliyon.2024.e36819. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39263087 Free PMC article.
-
New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma.Sci Rep. 2024 Sep 9;14(1):20977. doi: 10.1038/s41598-024-72020-y. Sci Rep. 2024. PMID: 39251678 Free PMC article. Review.
-
An in situ depot for the sustained release of a TLR7/8 agonist in combination with a TGFβ inhibitor promotes anti-tumor immune responses.Nat Commun. 2024 Sep 3;15(1):7687. doi: 10.1038/s41467-024-50967-w. Nat Commun. 2024. PMID: 39227589 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources